MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection

MLA

Paula Saz-Leal, et al. “MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. Coli in Experimental Urinary Tract Infection.” Vaccines, vol. 12, no. 5, May 2024, p. 535. EBSCOhost, https://doi.org/10.3390/vaccines12050535.

APA

Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, & Indira Uppugunduri Mysorekar. (2024). MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines, 12(5), 535. https://doi.org/10.3390/vaccines12050535

Chicago

Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, et al. 2024. “MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. Coli in Experimental Urinary Tract Infection.” Vaccines 12 (5): 535. doi:10.3390/vaccines12050535.